{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T22:32:03Z","timestamp":1784241123373,"version":"3.55.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,4,2]],"date-time":"2024-04-02T00:00:00Z","timestamp":1712016000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,4,2]],"date-time":"2024-04-02T00:00:00Z","timestamp":1712016000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Zhejiang Medical and Health Science and Technology Plan","award":["2022490202"],"award-info":[{"award-number":["2022490202"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Ovarian Res"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Polycystic ovarian syndrome (PCOS) is the most common endocrine disease in women of childbearing age which is often associated with abnormal proliferation or apoptosis of granulosa cells (GCs). Studies proved that long non-coding RNA SNHG12 (lncRNA SNHG12) is significantly increased in ovarian cancer and cervical cancer patients and cells. The inhibition of lncRNA SNHG12 restrains the proliferation, migration, and invasion in tumor cells.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Objective<\/jats:title>\n                <jats:p>This study explores the role of lncRNA SNHG12 in the apoptosis of GCs in PCOS and the underlying regulated mechanism.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>In this study, the injection of dehydroepiandrosterone (DHEA) successfully induced the PCOS model in SD rats. The human granulosa-like tumor cell line KGN was incubated with insulin to assess the effects of lncRNA SNHG12 on GC proliferation and apoptosis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Overexpression of lncRNA SNHG12 influenced the body weight, ovary weight, gonadal hormone, and pathological changes, restrained the expressions of microRNA (miR)-129 and miR-125b, while downregulation of lncRNA SNHG12 exerted the opposite effects in PCOS rats. After silencing lncRNA SNHG12 in cells, the cell viability and proliferation were lessened whereas apoptosis of cells was increased. A loss-of-functions test was implemented by co-transfecting miR-129 and miR-125b inhibitors into lncRNA SNHG12-knocking down cells to analyze the effects on cell viability and apoptosis. Next, the existence of binding sites of SNHG12 and miR-129\/miR-125b was proved based on the pull-down assay.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>lncRNA SNHG12 might be a potential regulatory factor for the development of PCOS by sponging miR-129 and miR-125b in GCs.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13048-024-01392-6","type":"journal-article","created":{"date-parts":[[2024,4,2]],"date-time":"2024-04-02T11:02:21Z","timestamp":1712055741000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["LncRNA SNHG12 promotes cell proliferation and inhibits apoptosis of granulosa cells in polycystic ovarian syndrome by sponging miR-129 and miR-125b"],"prefix":"10.1186","volume":"17","author":[{"given":"Feilan","family":"Xuan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruiying","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weimei","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongju","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuefang","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiali","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aixue","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,4,2]]},"reference":[{"issue":"4","key":"1392_CR1","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1097\/MOP.0000000000000778","volume":"31","author":"SF Witchel","year":"2019","unstructured":"Witchel SF, Burghard AC, Tao RH, Oberfield SE. The diagnosis and treatment of PCOS in adolescents: an update. Curr Opin Pediatr. 2019;31(4):562\u20139.","journal-title":"Curr Opin Pediatr"},{"issue":"2","key":"1392_CR2","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1007\/s40199-019-00312-0","volume":"27","author":"A Moini Jazani","year":"2019","unstructured":"Moini Jazani A, Nasimi Doost Azgomi H, Nasimi Doost Azgomi A, Nasimi Doost Azgomi R. A comprehensive review of clinical studies with herbal medicine on polycystic ovary syndrome (PCOS). Daru: J Fac Pharm Tehran Univ Med Sci. 2019;27(2):863\u201377.","journal-title":"Daru: J Fac Pharm Tehran Univ Med Sci"},{"key":"1392_CR3","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.jsbmb.2018.04.008","volume":"182","author":"S Patel","year":"2018","unstructured":"Patel S. Polycystic ovary syndrome (PCOS), an inflammatory, systemic, lifestyle endocrinopathy. J Steroid Biochem Mol Biol. 2018;182:27\u201336.","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"1","key":"1392_CR4","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1055\/s-0038-1668085","volume":"36","author":"ACH Neven","year":"2018","unstructured":"Neven ACH, Laven J, Teede HJ, Boyle JA. A summary on polycystic ovary syndrome: diagnostic criteria, prevalence, clinical manifestations, and management according to the latest international guidelines. Semin Reprod Med. 2018;36(1):5\u201312.","journal-title":"Semin Reprod Med"},{"issue":"7","key":"1392_CR5","doi-asserted-by":"publisher","first-page":"11976","DOI":"10.1002\/jcp.27854","volume":"234","author":"H Shen","year":"2019","unstructured":"Shen H, Wang Y. Activation of TGF-\u03b21\/Smad3 signaling pathway inhibits the development of ovarian follicle in polycystic ovary syndrome by promoting apoptosis of granulosa cells. J Cell Physiol. 2019;234(7):11976\u201385.","journal-title":"J Cell Physiol"},{"key":"1392_CR6","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.cca.2019.11.003","volume":"502","author":"X Zeng","year":"2020","unstructured":"Zeng X, Xie YJ, Liu YT, Long SL, Mo ZC. Polycystic ovarian syndrome: correlation between hyperandrogenism, insulin resistance and obesity. Clin Chim Acta. 2020;502:214\u201321.","journal-title":"Clin Chim Acta"},{"key":"1392_CR7","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.gene.2018.10.006","volume":"683","author":"T Wang","year":"2019","unstructured":"Wang T, Liu Y, Lv M, Xing Q, Zhang Z, He X, et al. Mir-323-3p regulates the steroidogenesis and cell apoptosis in polycystic ovary syndrome (PCOS) by targeting IGF-1. Gene. 2019;683:87\u2013100.","journal-title":"Gene"},{"issue":"2","key":"1392_CR8","doi-asserted-by":"publisher","first-page":"173","DOI":"10.21037\/atm-20-5044","volume":"9","author":"M Tu","year":"2021","unstructured":"Tu M, Wu Y, Mu L, Zhang D. Long non-coding RNAs: novel players in the pathogenesis of polycystic ovary syndrome. Annals Translational Med. 2021;9(2):173.","journal-title":"Annals Translational Med"},{"issue":"1","key":"1392_CR9","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s13048-020-00663-2","volume":"13","author":"J Tu","year":"2020","unstructured":"Tu J, Chen Y, Li Z, Yang H, Chen H, Yu Z. Long non-coding RNAs in ovarian granulosa cells. J Ovarian Res. 2020;13(1):63.","journal-title":"J Ovarian Res"},{"issue":"4","key":"1392_CR10","doi-asserted-by":"publisher","first-page":"3845","DOI":"10.1007\/s11033-021-06196-1","volume":"48","author":"M Abolghasemi","year":"2021","unstructured":"Abolghasemi M, Mahjoub S. Long noncoding RNAs as a piece of polycystic ovary syndrome puzzle. Mol Biol Rep. 2021;48(4):3845\u201351.","journal-title":"Mol Biol Rep"},{"key":"1392_CR11","doi-asserted-by":"publisher","first-page":"118174","DOI":"10.1016\/j.lfs.2020.118174","volume":"259","author":"M Abdalla","year":"2020","unstructured":"Abdalla M, Deshmukh H, Atkin SL, Sathyapalan T. miRNAs as a novel clinical biomarker and therapeutic targets in polycystic ovary syndrome (PCOS): a review. Life Sci. 2020;259:118174.","journal-title":"Life Sci"},{"issue":"3","key":"1392_CR12","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1111\/jcmm.17139","volume":"26","author":"M Tamaddon","year":"2022","unstructured":"Tamaddon M, Azimzadeh M, Tavangar SM. microRNAs and long non-coding RNAs as biomarkers for polycystic ovary syndrome. J Cell Mol Med. 2022;26(3):654\u201370.","journal-title":"J Cell Mol Med"},{"issue":"6","key":"1392_CR13","first-page":"2345","volume":"23","author":"D Sun","year":"2019","unstructured":"Sun D, Fan XH. LncRNA SNHG12 accelerates the progression of ovarian cancer via absorbing miRNA-129 to upregulate SOX4. Eur Rev Med Pharmacol Sci. 2019;23(6):2345\u201352.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"5","key":"1392_CR14","doi-asserted-by":"publisher","first-page":"6624","DOI":"10.1002\/jcp.27403","volume":"234","author":"XJ Jin","year":"2019","unstructured":"Jin XJ, Chen XJ, Zhang ZF, Hu WS, Ou RY, Li S, et al. Long noncoding RNA SNHG12 promotes the progression of cervical cancer via modulating miR-125b\/STAT3 axis. J Cell Physiol. 2019;234(5):6624\u201332.","journal-title":"J Cell Physiol"},{"issue":"1","key":"1392_CR15","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1080\/07853890.2022.2034933","volume":"54","author":"F Peng","year":"2022","unstructured":"Peng F, Hu Y, Peng S, Zeng N, Shi L. Apigenin exerts protective effect and restores ovarian function in dehydroepiandrosterone induced polycystic ovary syndrome rats: a biochemical and histological analysis. Ann Med. 2022;54(1):578\u201387.","journal-title":"Ann Med"},{"key":"1392_CR16","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.diabres.2017.06.011","volume":"130","author":"D Macut","year":"2017","unstructured":"Macut D, Bjeki\u0107-Macut J, Raheli\u0107 D, Dokni\u0107 M. Insulin and the polycystic ovary syndrome. Diabetes Res Clin Pract. 2017;130:163\u201370.","journal-title":"Diabetes Res Clin Pract"},{"issue":"1","key":"1392_CR17","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1111\/cen.13171","volume":"86","author":"R Zhang","year":"2017","unstructured":"Zhang R, Liu H, Bai H, Zhang Y, Liu Q, Guan L, et al. Oxidative stress status in Chinese women with different clinical phenotypes of polycystic ovary syndrome. Clin Endocrinol. 2017;86(1):88\u201396.","journal-title":"Clin Endocrinol"},{"issue":"1","key":"1392_CR18","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1186\/s12958-020-00677-x","volume":"18","author":"Y Gong","year":"2020","unstructured":"Gong Y, Luo S, Fan P, Zhu H, Li Y, Huang W. Growth hormone activates PI3K\/Akt signaling and inhibits ROS accumulation and apoptosis in granulosa cells of patients with polycystic ovary syndrome. Reprod Biol Endocrinol. 2020;18(1):121.","journal-title":"Reprod Biol Endocrinol."},{"issue":"10","key":"1392_CR19","doi-asserted-by":"publisher","first-page":"852","DOI":"10.21037\/atm-21-1614","volume":"9","author":"M He","year":"2021","unstructured":"He M, Mao G, Xiang Y, Li P, Wu Y, Zhao D, et al. MicroRNA-664a-3p inhibits the proliferation of ovarian granulosa cells in polycystic ovary syndrome and promotes apoptosis by targeting BCL2A1. Ann Transl Med. 2021;9(10):852.","journal-title":"Ann Transl Med"},{"issue":"6","key":"1392_CR20","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.ando.2020.11.008","volume":"81","author":"XL Ji","year":"2020","unstructured":"Ji XL, Liu X, Wang Z, Fang YC. Expression of ARID1A in polycystic ovary syndrome and its effect on the proliferation and apoptosis of ovarian granulosa cells. Ann Endocrinol. 2020;81(6):521\u20139.","journal-title":"Ann Endocrinol"},{"key":"1392_CR21","unstructured":"Sun HL, Tian MM, Jiang JX, Liu CJ, Zhai QL, Wang CY, et al. Does endoplasmic reticulum stress stimulate the apoptosis of granulosa cells in polycystic ovary syndrome?   J Physiol Pharmacol. 2021;72(5):785\u201392."},{"issue":"3","key":"1392_CR22","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1016\/j.ymthe.2020.11.018","volume":"29","author":"X Geng","year":"2021","unstructured":"Geng X, Zhao J, Huang J, Li S, Chu W, Wang WS, et al. lnc-MAP3K13-7:1 inhibits ovarian GC proliferation in PCOS via DNMT1 downregulation-mediated CDKN1A promoter hypomethylation. Mol Ther. 2021;29(3):1279\u201393.","journal-title":"Mol Ther"},{"issue":"1","key":"1392_CR23","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s13048-021-00792-2","volume":"14","author":"D Yang","year":"2021","unstructured":"Yang D, Wang Y, Zheng Y, Dai F, Liu S, Yuan M, et al. Silencing of lncRNA UCA1 inhibited the pathological progression in PCOS mice through the regulation of PI3K\/AKT signaling pathway. J Ovarian Res. 2021;14(1):48.","journal-title":"J Ovarian Res"},{"issue":"3","key":"1392_CR24","first-page":"1581","volume":"19","author":"R Yang","year":"2019","unstructured":"Yang R, Chen J, Wang L, Deng A. LncRNA BANCR participates in polycystic ovary syndrome by promoting cell apoptosis. Mol Med Rep. 2019;19(3):1581\u20136.","journal-title":"Mol Med Rep"},{"issue":"10","key":"1392_CR25","doi-asserted-by":"publisher","first-page":"8472","DOI":"10.1039\/D0FO01598A","volume":"11","author":"Y Zheng","year":"2020","unstructured":"Zheng Y, Zhang R, Shi W, Li L, Liu H, Chen Z, et al. Metabolism and pharmacological activities of the natural health-benefiting compound diosmin. Food Funct. 2020;11(10):8472\u201392.","journal-title":"Food Funct"},{"issue":"3","key":"1392_CR26","doi-asserted-by":"publisher","first-page":"e6079","DOI":"10.1590\/1414-431x20176079","volume":"50","author":"JZ Wang","year":"2017","unstructured":"Wang JZ, Xu CL, Wu H, Shen SJ. LncRNA SNHG12 promotes cell growth and inhibits cell apoptosis in colorectal cancer cells. Braz J Med Biol Res. 2017;50(3):e6079.","journal-title":"Braz J Med Biol Res"},{"key":"1392_CR27","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.steroids.2014.07.008","volume":"89","author":"F Plaza-Parrochia","year":"2014","unstructured":"Plaza-Parrochia F, Bacallao K, Poblete C, Gabler F, Carvajal R, Romero C, et al. The role of androst-5-ene-3\u03b2,17\u03b2-diol (androstenediol) in cell proliferation in endometrium of women with polycystic ovary syndrome. Steroids. 2014;89:11\u20139.","journal-title":"Steroids"},{"issue":"20","key":"1392_CR28","doi-asserted-by":"publisher","first-page":"3489","DOI":"10.1021\/bi400047u","volume":"52","author":"SC Jahn","year":"2013","unstructured":"Jahn SC, Law ME, Corsino PE, Rowe TC, Davis BJ, Law BK. Assembly, activation, and substrate specificity of cyclin D1\/Cdk2 complexes. Biochemistry. 2013;52(20):3489\u2013501.","journal-title":"Biochemistry"},{"issue":"5","key":"1392_CR29","doi-asserted-by":"publisher","first-page":"3597","DOI":"10.1016\/j.ygeno.2020.04.011","volume":"112","author":"HL Zhu","year":"2020","unstructured":"Zhu HL, Chen YQ, Zhang ZF. Downregulation of lncRNA ZFAS1 and upregulation of microRNA-129 repress endocrine disturbance, increase proliferation and inhibit apoptosis of ovarian granulosa cells in polycystic ovarian syndrome by downregulating HMGB1. Genomics. 2020;112(5):3597\u2013608.","journal-title":"Genomics"},{"issue":"2","key":"1392_CR30","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1177\/1933719118770544","volume":"26","author":"Y Yao","year":"2019","unstructured":"Yao Y, Reheman A, Xu Y, Li Q. miR-125b contributes to ovarian granulosa cell apoptosis through targeting BMPR1B, a major gene for sheep prolificacy. Reprod Sci. 2019;26(2):295\u2013305.","journal-title":"Reprod Sci"},{"key":"1392_CR31","doi-asserted-by":"publisher","first-page":"106175","DOI":"10.1016\/j.jsbmb.2022.106175","volume":"226","author":"T Li","year":"2023","unstructured":"Li T, Zhang T, Gao H, Wang H, Yan H, Wan Z, et al. Tempol modulates lncRNA-miRNA-mRNA ceRNA networks in ovaries of DHEA induced PCOS rats. J Steroid Biochem Mol Biol. 2023;226:106175.","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"1","key":"1392_CR32","doi-asserted-by":"publisher","first-page":"218","DOI":"10.3892\/mmr.2022.12734","volume":"26","author":"J Liu","year":"2022","unstructured":"Liu J, Zhao Y, Chen L, Li R, Ning Y, Zhu X. Role of metformin in functional endometrial hyperplasia and polycystic ovary syndrome involves the regulation of MEG3\/miR\u2013223\/GLUT4 and SNHG20\/miR\u20134486\/GLUT4 signaling. Mol Med Rep. 2022;26(1):218.","journal-title":"Mol Med Rep"}],"container-title":["Journal of Ovarian Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-024-01392-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13048-024-01392-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-024-01392-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,2]],"date-time":"2024-04-02T11:08:07Z","timestamp":1712056087000},"score":1,"resource":{"primary":{"URL":"https:\/\/ovarianresearch.biomedcentral.com\/articles\/10.1186\/s13048-024-01392-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,2]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1392"],"URL":"https:\/\/doi.org\/10.1186\/s13048-024-01392-6","relation":{},"ISSN":["1757-2215"],"issn-type":[{"value":"1757-2215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,2]]},"assertion":[{"value":"2 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The animal research was approved by the Ethics Committee of the Animal Center of the Zhejiang Eyong Pharmaceutical Research and Development Center. Animal use license number SYXK (Zhe) 2021-0033.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"N\/A","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"72"}}